These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2532751)

  • 41. Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans.
    Roth J; Zidovská J; Růzicková S; Havrdová E; Preiss M; Uhrová T; Línek V; Doubek P; Volfová M; Jech R; Bauer J; Růzicka E
    Sb Lek; 1999; 100(1):39-44. PubMed ID: 10860124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Magnetic resonance imaging in Huntington's disease.
    Sethi KD
    Mov Disord; 1991; 6(2):186. PubMed ID: 1829138
    [No Abstract]   [Full Text] [Related]  

  • 43. [Huntington's chorea: rigid-hypokinetic form (description of a case diagnosed by a biopsy of the caudate nucleus].
    Rodríguez Vallejo J; Portera A; Morales JM; Mata P; Merchán J
    Rev Clin Esp; 1973 Jun; 129(6):589-92. PubMed ID: 4269538
    [No Abstract]   [Full Text] [Related]  

  • 44. Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease.
    Nagel JS; Johnson KA; Ichise M; English RJ; Walshe TM; Morris JH; Holman BL
    Clin Nucl Med; 1988 Jul; 13(7):486-90. PubMed ID: 2971497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnostic problems in juvenile Huntington chorea].
    Woldag H; Strenge S; Weise K
    Nervenarzt; 1997 Aug; 68(8):667-70. PubMed ID: 9380214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Infantile Huntington's disease.
    Haslam RH; Curry B; Johns R
    Can J Neurol Sci; 1983 Aug; 10(3):200-3. PubMed ID: 6225502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thirteen years longitudinal study of computed tomography, visual electrophysiology and neuropsychological changes in Huntington's chorea patients and 50% at-risk asymptomatic subjects.
    Cala LA; Black JL; Collins DW; Ellison RM; Zubrick SA
    Clin Exp Neurol; 1990; 27():43-63. PubMed ID: 2151811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroacanthocytosis misdiagnosed as Huntington's disease: a case report.
    Meenakshi-Sundaram S; Arun Kumar MJ; Sridhar R; Rani U; Sundar B
    J Neurol Sci; 2004 Apr; 219(1-2):163-6. PubMed ID: 15050453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinicopathologic conference. Huntington's chorea.
    Dis Nerv Syst; 1972 Sep; 33(9):626-31. PubMed ID: 4265280
    [No Abstract]   [Full Text] [Related]  

  • 52. Reliability of the bicaudate parameter in the revealing of the enlarged lateral Ventricles in schizophrenia patients.
    Milovanović N; Damjanović A; Puškaš L; Milovanović S; Barišić J; Mališ M; Stanković G; Ranković A; Latas M; Filipović BF; Filipović BR
    Psychiatr Danub; 2018 Jun; 30(2):150-156. PubMed ID: 29930224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT.
    Pinborg LH; Videbaek C; Hasselbalch SG; Sørensen SA; Wagner A; Paulson OB; Knudsen GM
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):657-61. PubMed ID: 11309461
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Images in clinical medicine. Huntington's chorea.
    Malekpour M; Esfandbod M
    N Engl J Med; 2010 Oct; 363(15):e24. PubMed ID: 20925538
    [No Abstract]   [Full Text] [Related]  

  • 55. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene.
    Squitieri F; Esmaeilzadeh M; Ciarmiello A; Jankovic J
    Mov Disord; 2011 Apr; 26(5):925-7. PubMed ID: 21370274
    [No Abstract]   [Full Text] [Related]  

  • 56. On the pathological progression of Huntington's disease.
    Sieradzan KA; Mann DM
    Ann Neurol; 1998 Jul; 44(1):148-9. PubMed ID: 9667607
    [No Abstract]   [Full Text] [Related]  

  • 57. Huntington's disease, case report.
    Ivkosic A; Titlic M; Tadic T; Erceg I; Marovic A; Primorac D
    Neurol Neurochir Pol; 2003; 37(1):235-41. PubMed ID: 12910844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benzodiazepine receptor binding in Huntington's disease: [11C]flumazenil uptake measured using positron emission tomography.
    Künig G; Leenders KL; Sanchez-Pernaute R; Antonini A; Vontobel P; Verhagen A; Günther I
    Ann Neurol; 2000 May; 47(5):644-8. PubMed ID: 10805336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas. A PET study.
    Turjanski N; Weeks R; Dolan R; Harding AE; Brooks DJ
    Brain; 1995 Jun; 118 ( Pt 3)():689-96. PubMed ID: 7600086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Huntington's disease: a molecular genetic and CT comparison.
    Sharma P; Savy L; Britton J; Taylor R; Howick A; Patton M
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):206-8. PubMed ID: 8708657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.